11.01.2013 Views

Posters, 5th International Congress on Pediatric MDS and Bone ...

Posters, 5th International Congress on Pediatric MDS and Bone ...

Posters, 5th International Congress on Pediatric MDS and Bone ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<str<strong>on</strong>g>Posters</str<strong>on</strong>g>, <str<strong>on</strong>g>5th</str<strong>on</strong>g> <str<strong>on</strong>g>Internati<strong>on</strong>al</str<strong>on</strong>g> <str<strong>on</strong>g>C<strong>on</strong>gress</str<strong>on</strong>g> <strong>on</strong> <strong>Pediatric</strong> <strong>MDS</strong> <strong>and</strong> B<strong>on</strong>e Marrow Failure Syndromes 2009, Rotterdam<br />

Nr. AUTHORS TITLE<br />

PO-01 C<strong>on</strong>cetta Micalizzi, Johanna Svahn, Francesca Scuderi, Tiziana Lanza, Maura Faraci,<br />

Laura Banov, Michaela Calvillo, Oriana Burl<strong>and</strong>o, Francesca Fioredda, Daniela Caprino,<br />

Carlo Dufour.<br />

Chr<strong>on</strong>ic urticaria as first sign of <strong>MDS</strong><br />

PO-02 Noha M.El Hossainy(1)Mervat M. Mattar (2) prohepcidin in myelodysplasia<br />

PO-03 *A Piccin,^U Rovigatti,*C Mc Mah<strong>on</strong>,#J Kelly,##B Bourke,*A OíMarcaigh,*OP Smith THIOPURINE S-METHYL TRANSFERASE POLYMORPHIC STATUS, 6-MERCAPTOPURINE, AND<br />

TNF-ALPHA ANTAGONISM IN THE DEVELOPMENT OF MYELODYSPLASTIC SYNDROME /<br />

MONOSOMY 7 IN A CHILD WITH CROHN'S DISEASE<br />

PO-04 Valizadeh,Nasim Myelodysplastic syndrome(<strong>MDS</strong>) as an early manifestati<strong>on</strong> of Fanc<strong>on</strong>i anemia<br />

PO-05 Rekha Chaubey ,Sudha Sazawal , Manoranjan Mahapatra ,Renu Saxena RAS <strong>and</strong> FLT3-ITD gene mutati<strong>on</strong>s in patients with Myelodysplastic Syndromes in India: AIIMS<br />

experience<br />

PO-06 Shaoyan Hu1* Weiying Gu2 Hail<strong>on</strong>g He1 Yihuan Chai1 Shaoyan Hu <strong>and</strong> Weiying Gu The features of 65 Chinese pediatric patients with de novo myelodysplastic syndromes<br />

PO-07 Nao Yoshida 1), Hiroshi Yagasaki 2), Yoshiyuki Kosaka 3), Ryoji Kobayashi 4),<br />

Hiromasa Yabe 5), Takashi Kaneko 6), Masahiro Tsuchida 7), Akira Ohara 8),<br />

Tatsutoshi Nakahata 9), Seiji Kojima 2)<br />

PO-08 MuÒoz-Villa A , Diaz de Heredia , Diaz MA , Badell I , Martinez A , G<strong>on</strong>zalez-Valentin M<br />

, Dasi MA . Gomez P ,Bureo E , Olive T , Perez-Hurtado JM , Vicent MG <strong>and</strong> Mald<strong>on</strong>ado<br />

MS <strong>on</strong> behalf of GETMON<br />

Predicting resp<strong>on</strong>se to immunosuppressive therapy in childhood aplastic anemia<br />

Very severe acquired aplastic anemia: historical outcome of patients treated by allogeneic b<strong>on</strong>e<br />

marrow transplantati<strong>on</strong> from matched sibling d<strong>on</strong>ors. A study by the Spanish Group for Blood<br />

<strong>and</strong> Marrow Transplantati<strong>on</strong> in Children (GETMON)<br />

PO-09 Masafumi Ito, Ryoichi Ichihashi, Masahiko Fujino, Seiji Kojima* Absence of Hemoglobin F expressi<strong>on</strong> <strong>on</strong> b<strong>on</strong>e marrow erythroblasts identifies a distinct subset<br />

of acquired aplastic anemia patients with good resp<strong>on</strong>se to immunosuppressive therapy<br />

PO-10 Ferrara M., Capozzi L., Russo R. INCIDENCE OF MALIGNANCY IN A FAMILY OF A PATIENT WITH FANCONI ANAEMIA (FA)<br />

PO-11 Perolla.A , Caja.T, Xhumari.P , Pulluqi.P , Pushi. A PANCYTOPENIA- First expressi<strong>on</strong> of several blood diseases [ a 10 years study ]<br />

PO-12 M.Sukova(1),E.Mejstrikova(2),S.Pekova(3),J.Cermak(4),D.Pospisilova(5),J.Stary(1) Childhood paroxysmal nocturnal hemoglobinuria/aplastic anemia (PNH/AA) syndrome - analysis<br />

for PNH cl<strong>on</strong>al evoluti<strong>on</strong> after immunosuppressive therapy<br />

PO-13 Isabelle Meyts, Marleen Renard, Johan Maertens*, Ann Uyttebroeck Salvage allogeneic stem cell transplantati<strong>on</strong> in a child with severe aplastic anemia in the course<br />

of life-threatening potential invasive fungal lung infecti<strong>on</strong> with peri- <strong>and</strong> myocardial infiltrati<strong>on</strong><br />

PO-14 RAHIM F 1,2,PANAHI M 3,RASHIDI I4 Incidence of Aplastic Anaemia in Khuzestan Province, Iran: A Retrospective Single-Centre Study<br />

page 1/ 4


<str<strong>on</strong>g>Posters</str<strong>on</strong>g>, <str<strong>on</strong>g>5th</str<strong>on</strong>g> <str<strong>on</strong>g>Internati<strong>on</strong>al</str<strong>on</strong>g> <str<strong>on</strong>g>C<strong>on</strong>gress</str<strong>on</strong>g> <strong>on</strong> <strong>Pediatric</strong> <strong>MDS</strong> <strong>and</strong> B<strong>on</strong>e Marrow Failure Syndromes 2009, Rotterdam<br />

Nr. AUTHORS TITLE<br />

PO-15 Ver<strong>on</strong>ica M.E. Neefjes(1), Rienk Y.J. Tamminga(2) ATG IN ACQUIRED APLASTIC ANAEMIA; IS LESS MORE?<br />

PO-16 Pallota, R<strong>on</strong>ald 1; Gomes, LaÌs 1 Aplastic Anemia sec<strong>on</strong>dary to Dengue virus infecti<strong>on</strong>: A Case Report<br />

PO-17 Vallero S, Quarello P, Lorenzati A, Renga D, Rivetti E, Laudati R, Farinasso L, Timeus F,<br />

Ramenghi U, Saracco P<br />

PO-18 Dr. Maitreyee Bhattacharyya, Dr. Seema Tyagi, Dr. M Mahapatra, Dr. V.P. Chaudhury,<br />

Dr. Renu Saxena<br />

PO-19 F Timeus, N Crescenzio, P Quarello, A Doria, L Foglia, S Pagliano, A Lorenzati, S<br />

Vallero, L Farinasso, P Saracco.<br />

PO-20 Saracco P, Quarello P, Iori AP, Zecca M, L<strong>on</strong>g<strong>on</strong>i D, Svahn J, Varotto S, Del Vecchio<br />

GC, Dufour C, Ramenghi U, Bacigalupo A, Locasciulli A; B<strong>on</strong>e Marrow Failure Study<br />

Group of the AIEOP<br />

PO-21 1 Mahfuzah Mohamed, 1 Eni Juraida A. Rahman, 2 Bina S Men<strong>on</strong>, 1 Caroline Ho, 1<br />

Raja Khuzaiah, 1 Zulaiha Muda, 1 Ida Shahnaz Othman, 1 Lim Yin Sear, 1 Asohan<br />

Thevarajah, 1 Aisyah M. Rivai, 1 Hishamshah M. Ibrahim<br />

Use of pegylated granulocyte-col<strong>on</strong>y stimulating factor (PG-CSF) in childhood severe aplastic<br />

anemia.<br />

Etiopathogenesis of childhood aplasticc anemia -- a single center study of 94 cases.<br />

Paroxysmal nocturnal hemoglobinuria cl<strong>on</strong>es in children with acquired aplastic anemia: a single<br />

centre study.<br />

Cyclosporin A resp<strong>on</strong>se <strong>and</strong> dependence in children with acquired aplastic anaemia: an update<br />

of a multicentre retrospective study with l<strong>on</strong>g-term observati<strong>on</strong> follow-up.<br />

Immunosupressti<strong>on</strong> therapy in children with severe aplastic anaemia<br />

PO-22 Karolien Beel1, Melanie M. Cotter2, Peter V<strong>and</strong>enberghe1 Is the risk of developing AML or <strong>MDS</strong> increased in X-linked neutropenia ?<br />

PO-23 Albert Catala; Susana Rives; Teresa Toll; Mireia CamÛs; Ruben Berrueco; Nuria<br />

C<strong>on</strong>de; Ana Quintero; JI Arostegui*; Jes˙s Estella<br />

PO-24 M.B. Bierings2, S.N. van der Crabben1, E. van Binsbergen1, M.G.E.M. Ausems1<strong>and</strong> A.<br />

Buijs1<br />

PO-25 Dr. Maitreyee Bhattacharyya, Dr. Seema Tyagi, Dr. Manoranjan Mahapatra, Dr. V.P.<br />

Chaudhury, Dr. Renu Saxena<br />

PO-26 Tim Ripperger (+), Doris Steinemann (+), Gudrun Gˆhring (+), Charlotte Niemeyer<br />

(*), Brigitte Strahm (*), <strong>and</strong> Brigitte Schlegelberger (+)<br />

PO-27 Daisuke Hasegawa, Chitose Ogawa, Shinsuke Hirabayashi, Myoung-ja Park, Yasuhide<br />

Hayashi, Atsushi Manabe, Ryota Hosoya.<br />

PO-28 Yoshitoshi Ohtsuka, Mayumi Sugita, Yuka Nakajima, Junichiro Ono, Noriaki Okamoto,<br />

Yuichi Yokokawa, Hiroshi Y<strong>on</strong>eyama, Takashi Kaneko, Takakuni Tanizawa.<br />

page 2/ 4<br />

IMPROVING CONGENITAL NEUTROPENIA DIAGNOSIS: MUTATIONAL ANALYSIS OF ELA2 AND<br />

HAX1 GENES. A SINGLE CENTRE EXPERIENCE<br />

N<strong>on</strong>-syndromic c<strong>on</strong>stituti<strong>on</strong>al RUNX1 deleti<strong>on</strong> presenting as thrombocytopenia with<br />

myelodysplasia.<br />

Childhood aplastic anemia in search for inherited status.<br />

A further pedigree with germline RUNX1 mutati<strong>on</strong> <strong>and</strong> propensity to myeloid malignancies<br />

A Japanese pedigree with RUNX1 mutati<strong>on</strong> resulting in familial platelet disorder with propensity<br />

to acute myelogenous leukemia (FPD/AML)<br />

Successful unrelated b<strong>on</strong>e marrow transplantati<strong>on</strong> for two patients with amegakaryocytic<br />

thrombocytopenia with radio-ulnar synostosis in Japan.


<str<strong>on</strong>g>Posters</str<strong>on</strong>g>, <str<strong>on</strong>g>5th</str<strong>on</strong>g> <str<strong>on</strong>g>Internati<strong>on</strong>al</str<strong>on</strong>g> <str<strong>on</strong>g>C<strong>on</strong>gress</str<strong>on</strong>g> <strong>on</strong> <strong>Pediatric</strong> <strong>MDS</strong> <strong>and</strong> B<strong>on</strong>e Marrow Failure Syndromes 2009, Rotterdam<br />

Nr. AUTHORS TITLE<br />

PO-29 Ferrara M., Capozzi L., Russo R. A case of C<strong>on</strong>genital Dyserythropoietic Anemia type II (CDA II)<br />

PO-30 I. Furlan, U. Graubner, A. Karow, C. P. Kratz, C.M. Niemeyer Liver fibrosis <strong>and</strong> telomere maintenance: a family with dyskeratosis c<strong>on</strong>genita<br />

PO-31 1Hashmi SK, 1Allen C, 2Klaassen R, 3Fern<strong>and</strong>ez CV, 4Yanofsky R, 5Wu J,<br />

6Champagne J, 7Silva M, 8Lipt<strong>on</strong> JH, 9Brossard J, 10Sams<strong>on</strong> Y, 11Abish S, 12Steele<br />

M, 13Ali K, 14Dower N, 15Athale U, 16Jardine L, 17H<strong>and</strong> JP, 13Beyene J, 1Dror Y<br />

PO-32 Segbefia C, Klaassen R, Fern<strong>and</strong>ez CV, Yanofsky R, Sherek E, Champagne J, Silva M,<br />

Lipt<strong>on</strong> JH, Brossard J, Sams<strong>on</strong> Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine<br />

L, H<strong>and</strong> JP, Allen C, Beyene J, Dror Y<br />

PO-33 BenoÓte Perez (1,2), Julie Lachenaud (1,2), Sabrina Pereira(1), Marie Laurence<br />

Menot(2), CÈline Liger(1), Fabien Zassadowski(2), Corinne Alberti(3), Christine<br />

Chomienne(2), Bruno Cassinat(2), HÈlËne CavÈ(1,2).<br />

PO-34 Vallero S, Aschero S, Garbarini L, Mazz<strong>on</strong>e R, Crescenzio N, Iavar<strong>on</strong>e A, Ricotti E,<br />

Vassallo E, Nesi F, Cordero di M<strong>on</strong>tezemolo L, Farinasso L<br />

PO-35 A.C.H. de Vries (1), R.G.M. Bredius (2), A.C. Lankester (2), M. Bierings (3), M. Trebo<br />

(4), P. Sedlacek (5), C.M. Niemeyer (6), M. Zecca (7), F. Locatelli (7), M.M. van den<br />

Heuvel-Eibrink (1)<br />

PO-36 Miharu Yabe, Atsushi Manabe, Yoshitoshi Ohtsuka, Kenichirou Watanabe, Masaru<br />

Imamura, Makoto Kaneda, Ryousuke Miyachi, Jirou Inagaki, Yasuhiro Ebihara, Nao<br />

Yoshida, Kazuo Sakashita, Keizo Horibe, Masahito Tsurusawa<br />

COMPARATIVE ANALYSIS OF SHWACHMAN-DIAMOND SYNDROME TO OTHER INHERITED<br />

MARROW FAILURE SYNDROMES<br />

MALIGNANT MYELOID TRANSFORMATION IN INHERITED BONE MARROW FAILURE SYNDROMES<br />

NRAS, KRAS, PTPN11 <strong>and</strong> NF1 mutati<strong>on</strong>s lead to in vitro <strong>and</strong> clinical differences in Juvenile<br />

Myelom<strong>on</strong>ocytic Leukemia (JMML)<br />

Del(5q) in a patient with JMML, neurofibromatosis 1 <strong>and</strong> Parvovirus B19 infecti<strong>on</strong>.<br />

HLA-IDENTICAL UMBILICAL CORD BLOOD TRANSPLANTATION FROM A SIBLING DONOR IN<br />

JUVENILE MYELOMONOCYTIC LEUKEMIA<br />

Allogeneic hematopoietic stem cell transplantati<strong>on</strong> with fludarabine-c<strong>on</strong>taining regimen in<br />

children with juvenile myelom<strong>on</strong>ocytic leukemia<br />

PO-37 Christine Dahl(1), Gitte B. Kerndrup (2), Jan Stary (3), Henrik Hasle (1) Expressi<strong>on</strong> of p53 in myelodysplastic syndrome, JMML <strong>and</strong> n<strong>on</strong>-neoplastic b<strong>on</strong>e marrow failures<br />

in children.<br />

PO-38 Arzu Akyay*, Lale Olcay*, Mehmet Ertem**, I nsu Kuzu**, Nazan Bozdo an*, Elif ‹nal<br />

nce**, Talia leri**, Bet¸l Tavil*, Ay e Say l **, Z¸mr¸t Uysal**<br />

A CASE OF MYELODYSPLASTIC SYNDROME WITH HYPOCELLULER FIBROSIS<br />

PO-39 Maria Helena Ornellas1,2, Mercia Mendes Campos2 Claudia Diniz Athaide2, Bernadete IMMUNOPHENOTYPIC PROFILE IN PEDIATRIC PATIENTS WITH MYELODYSPLASTIC SYNDROME<br />

Evangelho Gomes2,Karen Wagner-Souza2, Teresa de Souza Fern<strong>and</strong>ez1,2 Hilda Rachel IN RIO DE JANEIRO, BRAZIL<br />

Diam<strong>on</strong>d2<br />

PO-40 Roos J Leguit, Marrie CA Bruin, Marc B Bierings, Jan G van den Tweel The pathological findings <strong>and</strong> survival in pediatric b<strong>on</strong>e marrow failure syndromes. A single<br />

centre review<br />

PO-41 Rinaldi CR 1, Rinaldi P 1, Martinelli V 1, Ciancia R 1, Gugliotta L 2, Vannucchi AM 3,<br />

Barbui T 4, Rotoli B 1 <strong>and</strong> Pane F 1.<br />

PO-42 Shinsuke Hirabayashi, Keitaro Arima, Takahiro Kamiya, Daisuke Hasegawa, Chitose<br />

Ogawa, Atsushi Manabe, Ryota Hosoya, Etsuro Ito*<br />

page 3/ 4<br />

JAK2 V617F mutati<strong>on</strong> in Acute Myeloid Leukemia Sec<strong>on</strong>dary to Ph negative Chr<strong>on</strong>ic<br />

Myeloproliferative Disorders<br />

C<strong>on</strong>genital myeloproliferative disease (MPD) with GATA-1 mutati<strong>on</strong> in a phenotypically normal<br />

infant


<str<strong>on</strong>g>Posters</str<strong>on</strong>g>, <str<strong>on</strong>g>5th</str<strong>on</strong>g> <str<strong>on</strong>g>Internati<strong>on</strong>al</str<strong>on</strong>g> <str<strong>on</strong>g>C<strong>on</strong>gress</str<strong>on</strong>g> <strong>on</strong> <strong>Pediatric</strong> <strong>MDS</strong> <strong>and</strong> B<strong>on</strong>e Marrow Failure Syndromes 2009, Rotterdam<br />

Nr. AUTHORS TITLE<br />

PO-43 Sudha Sazawal, Jyoti Bajaj, Bharti Sharma, Rahul Bhargava, Rekha Chaubey,<br />

Manoranjan Mahapatra, Renu Saxena<br />

PO-44 Dagmar Pospisilova1, M<strong>on</strong>ika Horvathova2, Jitka Veselovska2, Renata Solna2, Jana<br />

Kucerova2, Jan Stary3, Kveta Petrtylova3, S<strong>on</strong>a Pekova4, Vladimir Divoky2<br />

PO-45 J<strong>and</strong>a A.(1), Cermak J.(2), Petrtylova K.(3), Cerna Z.(4), Zemanova Z.(5), Markova<br />

M.(2), Mejstrikova E.(1), Smisek P.(1), Stary J.(1)<br />

PO-46 Laurent Garderet 1,2,3, Ladan Kobari 1,2, Christelle Mazurier 1,4, Caroline De Witte<br />

1,2, Marie-Catherine Giarratana 1,2, Christine PÈrot 5, HÈlËne Lapill<strong>on</strong>ne 1,2,6 & Luc<br />

Douay 1,2,4,6<br />

PO-47 Per O. Iversen (1,2), Elvira Semaeva (3), Dag R. Sorensen (4), Helge Wiig (3) <strong>and</strong><br />

Mouldy Sioud (5)<br />

Frequency of JAK2 V617F in Indian patients with Chr<strong>on</strong>ic myeloproliferative disorders: AIIMS<br />

experience<br />

ESSENTIAL THROMBOCYTHAEMIA IN CHILDREN: CLINICAL AND LABORATORY<br />

CHARACTERISTICS<br />

Cytopenia progressing slowly towards full-blown <strong>MDS</strong>-RC, three case reports.<br />

Myelodysplastic 5q(del) cl<strong>on</strong>es are able to reach terminal differentiati<strong>on</strong> into enucleated red<br />

blood cells.<br />

A combined immunostimulatory <strong>and</strong> immunoinhibitory siRNA with anti-leukemic properties in a<br />

rat model of acute myeloid leukemia<br />

PO-48 Yang-Ping Niu, Xu-Dai Qian, Jun-Qing Qian PROLIFERATIVE EFFECTS OF GPD AND GPT ON HUMAN BONE MARROW HAEMOPOIETIC<br />

PROGENITOR CELLS<br />

PO-49 Bing Han, Juan xiao, Y<strong>on</strong>gji Wu, Yuping Zh<strong>on</strong>g, Wanling Sun Ex vivo expansi<strong>on</strong> <strong>and</strong> hematopoietic rec<strong>on</strong>stituti<strong>on</strong> ability of isolated CD34+CD59+ cells from<br />

patients with paroxysmal nocturnal hemoglobinuria<br />

PO-50 S. Lie F<strong>on</strong>g, M.D. (1), J.S.E. Laven, Ph.D. (1), F.G.A.J. Hakvoort-Cammel, M.D. (2), I.<br />

Schipper, Ph.D. (1), J.A. Visser, Ph.D. (3), A.P.N. Themmen, Ph.D. (3), F.H. de J<strong>on</strong>g,<br />

Ph.D. (3), M.M. van den Heuvel - Eibrink, Ph.D. (2).<br />

PO-51 D.Woijcik1,2,J.Musia 1,E.Gorczy ska1,M.Ussowicz1,A.Dyla1,J.Owoc-Lempach1,M. S<br />

ociak1,D.Sega-P<strong>on</strong>del1,W.Pietras1 <strong>and</strong> K.Ka wak1<br />

PO-52 Igor Resnick, Polina Stepensky, Michael Weintraub, Dani Engelhard, Diana Averbukh,<br />

Jacqueline Feinberg, StÈphanie Boiss<strong>on</strong>-Dupuis, Jacinta Bustamante, Jean-Laurent<br />

Casanova.<br />

page 4/ 4<br />

G<strong>on</strong>adal damage in female adult childhood cancer survivors after total body irradiati<strong>on</strong>,<br />

assessed by anti-M¸llerian horm<strong>on</strong>e<br />

Haematopoietic Stem Cell Transplantati<strong>on</strong> (HSCT) for pediatric <strong>MDS</strong>-Single center study-<br />

A NOVEL FORM OF MYELODYSPLASTIC SYNDROME (<strong>MDS</strong>) ASSOCIATED WITH MENDELIAN<br />

SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE (MSMD).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!